XML 56 R44.htm IDEA: XBRL DOCUMENT v3.8.0.1
Collaborative Arrangements - Narrative (Details) - USD ($)
$ in Millions
1 Months Ended 3 Months Ended 12 Months Ended
Jan. 31, 2018
Jul. 31, 2017
Mar. 31, 2018
Mar. 31, 2017
Dec. 31, 2018
Dec. 31, 2017
Collaborative Arrangements and Non-collaborative Arrangement Transactions [Line Items]            
Research and development     $ 3,196 $ 1,830    
Accrued and other current liabilities     9,709     $ 10,427
Sales     10,037 $ 9,434    
AstraZeneca            
Collaborative Arrangements and Non-collaborative Arrangement Transactions [Line Items]            
Upfront and milestone payments   $ 1,600        
Payments to acquire intangible assets   750       250
Research and development           2,350
Contingent payments collaborative arrangement $ 70 6,150        
Total consideration collaborative arrangement (up to value)   8,500        
AstraZeneca | Future Regulatory Milestones            
Collaborative Arrangements and Non-collaborative Arrangement Transactions [Line Items]            
Contingent payments collaborative arrangement $ 1,980 2,050        
AstraZeneca | Future Sales-Based Milestones            
Collaborative Arrangements and Non-collaborative Arrangement Transactions [Line Items]            
Contingent payments collaborative arrangement   $ 4,100 3,850      
AstraZeneca | Lynparza            
Collaborative Arrangements and Non-collaborative Arrangement Transactions [Line Items]            
Accrued and other current liabilities     150     100
Amortization expense for intangible assets     9      
AstraZeneca | Lynparza | Forecast            
Collaborative Arrangements and Non-collaborative Arrangement Transactions [Line Items]            
Contingent payments collaborative arrangement         $ 150  
Bayer AG | Future Sales-Based Milestones            
Collaborative Arrangements and Non-collaborative Arrangement Transactions [Line Items]            
Contingent payments collaborative arrangement     775      
Bayer AG | Adempas            
Collaborative Arrangements and Non-collaborative Arrangement Transactions [Line Items]            
Contingent payments collaborative arrangement     $ 350      
Sales           $ 500